1. Toll-like receptor 9 expression in the natural history of Barrett mucosa
    Heikki Huhta et al, 2015, Virchows Arch CrossRef
  2. Folic acid modulates cancer-associated micro RNAs and inflammatory mediators in neoplastic and non-neoplastic colonic cells in a different way
    Birgit Niemann et al, 2017, Mol. Nutr. Food Res. CrossRef
  3. The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer
    Heikki Huhta et al, 2016, J Histochem Cytochem. CrossRef
  4. TLR3 expression status predicts prognosis in patients with advanced thoracic esophageal squamous cell carcinoma after esophagectomy
    Yusuke Sato et al, 2018, The American Journal of Surgery CrossRef
  5. Extracellular DNA promotes colorectal tumor cell survival after cytotoxic chemotherapy
    Reginald Anunobi et al, 2018, Journal of Surgical Research CrossRef
  6. Role of TLR9 in Oncogenic Virus-Produced Cancer
    Cecilia Martínez-Campos et al, 2017, Viral Immunology CrossRef
  7. Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-β signaling axis in paclitaxel-resistant colon cancer
    Jiaojiao Zhao et al, 2018, J Cell Physiol CrossRef
  8. null
    Yann Estornes et al, 2017 CrossRef
  9. Circulating cell-free mitochondrial DNA as the probable inducer of early endothelial dysfunction in the prediabetic patient
    Noé Alvarado-Vásquez, 2015, Experimental Gerontology CrossRef
  10. Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention
    Hai Zou et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
  11. Cell membrane and intracellular expression of toll-like receptor 9 (TLR9) in colorectal cancer and breast cancer cell-lines
    Shadab Shahriari et al, 2017, CBM CrossRef
  12. Cleavable conjugation of CpG oligodeoxynucleotides onto microparticles for facile release and cytokine induction in macrophages
    Hyo-Eun Jang et al, 2017, Appl Biol Chem CrossRef
  13. Epistatic effect of TLR3 and cGAS‐STING‐IKKε‐TBK1‐IFN signaling variants on colorectal cancer risk
    Calogerina Catalano et al, 2019, Cancer Med CrossRef
  14. Combinatorial treatment with polyI:C and anti-IL6 enhances apoptosis and suppresses metastasis of lung cancer cells
    Wai Hoe Lau et al, 2017, Oncotarget CrossRef
  15. Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma
    Lovisa Farnebo et al, 2015, Oncotarget CrossRef
  16. null
    Mahmud Angrini et al, 2020 CrossRef

  17. Toll-Like Receptor 3 as a Recurrence Risk Factor and a Potential Molecular Therapeutic Target in Colorectal Cancer


    Tatsuya Yoshida et al, 2020, CEG CrossRef
  18. Roles of Toll-Like Receptor 3 in Human Tumors
    Xin Zheng et al, 2021, Front. Immunol. CrossRef
  19. Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
    Fernando Torres Andón et al, 2022, Biomedicines CrossRef
  20. The Association Between Gut Microbiota, Toll-Like Receptors, and Colorectal Cancer
    Yongkun Fang et al, 2022, Clin Med Insights Oncol CrossRef
  21. Dietary nano-Selenium improves health of liver and intestine of grass carp Ctenopharyngodon idella after overwintering
    Limin Ye et al, 2023, Animal Feed Science and Technology CrossRef
  22. Toll-like receptor 3 signaling attenuated colitis-associated cancer development in mice
    Kee Young Chung et al, 2024, Sci Rep CrossRef